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ii. Summary/Abstract 
The use of synthetically-synthesized azide and alkyne fatty acid analogues coupled with 
bioorthogonal Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition reaction-based detection 
methods to study protein S-acylation reactions has replaced the traditional method of using in 
vivo metabolic radiolabelling with tritiated palmitic acid and has greatly facilitated our 
understanding of this essential cellular process.  Here, we describe the chemical synthesis of 
myristic (C:14), palmitic (C16:0) and stearic (C18:0) acid-azide probes and detail how they 
may be utilized as chemical reporters for the analysis of S-acylation of exogenously 
expressed proteins in cells. 
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1. Introduction 
Protein S-acylation (palmitoylation) describes the reversible post-translational attachment of 
fatty acids on to cysteine amino acids.  Although palmitic acid (C16:0) is the most frequent 
fatty acid to modify proteins in this way, other shorter and longer chain saturated and 
unsaturated fatty acids may be added on to S-acylated proteins [1-6].  Historically, the only 
method to detect protein S-acylation was by in vivo metabolic radiolabelling using tritiated 
palmitate followed by fluorographic detection [7-9]. Despite being the primary method used 
for decades, this approach has several limitations, including a low signal intensity that 
requires long exposure times (up to three months) in the order for S-acylation to be detected. 
Over the past decade, however, there has been a significant advance over this traditional 
methodology through the use of synthetically-synthesized azide and alkyne fatty acid 
analogues as alternatives to tritiated palmitic acid [10-17]. These fatty acid analogues mimic 
endogenous fatty acids and can be utilised as reporters of cellular processes involving fatty 
acids, such as protein S-acylation [6]. Coupled with bioorthogonal Cu(I)-catalyzed Huisgen 
1,3-dipolar cycloaddition (‘Click’) reaction-based detection methods, the use of azide and 
alkyne fatty acid analogues is a highly sensitive, quantitative and practical method for 
studying protein S-acylation reactions that can be adapted for high-throughput analysis [18]. 
Since fatty acyl chain diversity can also be incorporated during the synthesis of these 
chemical probes, these reporters facilitate our understanding of how acyl chain heterogeneity 
contributes to protein S-acylation [6].   
This method describes the detection of S-acylation of EGFP-tagged synaptosomal-associated 
protein of 25 kDa (SNAP25), expressed in HEK293T cells along with hemagglutinin (HA)-
tagged zDHHC3 as a catalyst, using chemically-synthesized myristic (C14:0), palmitic 
(C16:0) and stearic (C18:0) acid azide probes. Detection of S-acylation of other substrate 
proteins may not necessarily require the co-expression of a zDHHC enzyme [19]. HEK293 
cells are a well-established mammalian cell line used for heterologous protein expression due 
to their efficient transfection rate and subsequent high level expression of proteins from 
plasmid DNA [20]. In this method, HEK293T cells are transiently transfected using 
Lipofectamine 2000 transfection reagent (Invitrogen) with a plasmid encoding the S-acylated 
protein of interest. Following high-level expression, cells are labelled with the synthetically 
synthesized fatty acid-azide probes, which can become metabolically incorporated into S-
acylated and other lipidated cellular proteins. The azido-fatty acid modification on cellular 
proteins is then conjugated to an alkyne infrared fluorophore by performing a Cu(I)-catalyzed 
‘Click’ reaction.  Isolated cellular proteins are then resolved electrophoretically in vertical 
discontinuous sodium dodecyl sulphate polyacrylamide gels according to the Laemmli 
method [21] and expression of exogenous proteins is confirmed by western blotting.   
 
2. Materials 
2.1 Reduction of carboxylic acids 
1. Hotplate stirrer 
2. Cryogenic bath for cooling 
3. Spatula 
4. 500 mL B24 round bottom flask 
5. B24 suba seal 
6. Schlenk line 
7. 250 mL measuring cylinder 
8. Sintered filter funnel with side-arm 
9. B24 water condenser 
10. Tubing for water condenser 
11. Silicone oil bath 
12. Magnetic stirrer bar 
13. Pressure tubing for filtration 
14. 1 L separating funnel with stopper 
15. 2 x 500 mL conical flask 
16. Rotary evaporator 
 2.2 Bromination of diols 
1. Hotplate stirrer 
2. Spatula 
3. 2 neck 250 mL B24 round bottom flask 
4. B24 glass stopper 
5. B24 100 ml pressure equalising dropping funnel 
6. Silicone oil bath for heating 
7. 250 mL measuring cylinder 
8. Sintered filter funnel with side-arm 
9. B24 water condenser 
10. Tubing for water condenser 
11. Magnetic stirrer bar 
12. 500 mL separating funnel with stopper 
13. Pressure tubing for filtration 
14. 3 x 250 mL conical flask 
15. 80 x 3 cm glass column with ball joint for chromatography 
16. Rotary evaporator 
 
2.3 Oxidation of primary alcohols 
1. Hotplate stirrer 
2. Spatula 
3. 100 mL B24 round bottom flask 
4. B24 glass stopper 
5. 100 mL measuring cylinder 
6. Sintered filter funnel with side-arm 
7. Magnetic stirrer bar 
8. Pressure tubing for filtration 
9. 250 mL separating funnel with stopper 
10. 3 x 250 mL conical flask 
11. 80 x 3 cm column with ball joint for flash chromatography 
12. 100 mL conical flask 
13. Rotary evaporator 
 
2.4 Azide addition 
1. Hotplate stirrer 
2. Schlenk line 
3. Spatula 
4. 50 mL B24 round bottom flask 
5. B24 suba seal 
6. Schlenk line 
7. 50 mL measuring cylinder 
8. Sintered filter funnel with side-arm 
9. B24 water condenser 
10. Tubing for water condenser 
11. Silicone oil bath 
12. Magnetic stirrer bar 
13. Pressure tubing for filtration 
14. 100 mL separating funnel with stopper 
15. 3 x 100 mL conical flask 
16. Rotary evaporator 
 
2.5 Cell Culture Reagents and Equipment  
1. Human Embryonic Kidney 293T (HEK293T) cell culture media: DMEM containing 
L-Glutamine and 10 % Foetal Bovine Serum, store at 4 C.  
2. Trypsin-EDTA (0.05%). 
3. Lipofectamine 2000 (Invitrogen) transfection reagent, store at 4 C. 
4. Fatty-acid free cell culture media: DMEM containing L-Glutamine and supplemented 
with 1 mg/ml of fatty-acid free Bovine Serum Albumin. 
5. Fatty-acid azides: Saturated fatty acid azides are stored at -20 C as 100 mM stocks 
made up in DMSO (See Note 1). 
6. Fatty-acid azide labelling cell culture media: Fatty-acid free cell culture media 
containing100 µM fatty-acid azide. 
7. Poly-D-lysine coated 24-well cell culture plates. 
8. T75 flasks 
9. Pipettes 
10. Pipette Gun 
11. Falcon tubes 
12. Sterile 1.5 ml tubes 
13. Laminar Flow tissue culture hood 
14. Neubauer Chamber 
15. Light microscope 
 
2.6 Click chemistry 
1. Phosphate-buffered Saline (PBS; 10X): 1.37 M NaCl, 27 mM KCl, 100 mM 
Na2HPO4, 18 mM KH2PO4, pH 7.4. (See Note 2.)  
2. Lysis Buffer: 50 mM Tris, pH 8.0, 0.5% SDS. Store at 4 C. Protease inhibitors 
should be added immediately before use.  
3. LI-COR IRDye® 800CW Alkyne Infrared Dye (LI-COR Biotechnology UK Ltd, 
Catalogue number 929-60002): Resuspend in Dimethyl Sulfoxide (DMSO) at a 
concentration of 4mM and store stock solutions in aliquots at - 20 C for short –term 
or - 80 C for long-term storage (See Note 3).  
4. Copper Sulphate: 40 mM solution.  
5. Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA): Resuspend in DMSO at 
a concentration of 100 mM and store stock solutions in small aliquots at - 20 C. 
6. Ascorbic acid: 4 mM solution (See Note 4).  
7. Acetone: 100 % and 70 % stock solutions stored at - 20 C (See Note 5).  
8. End-over-end rotator. 
 
 
2.7 SDS-Polyacrylamide Gel Electrophoresis 
1. SDS Lysis buffer (4X): 200mM Tris-HCl, pH 6.8, 40% Glycerol, 8% Sodium 
Dodecyl Sulphate (SDS) (See Note 6), 0.4% Bromophenol Blue, supplemented with 
25 mM DTT (See Note 7).  
2. Dithiothreitol (DTT): 1M stock made up in dH20 and stored in 1 ml aliquots at – 
20C. 
3. Resolving gel buffer (2 X): 750 mM Tris-HCl, pH 8.9, 4 mM 
Ethylenediaminetetraacetic acid (EDTA), 0.2% SDS. 
4. Stacking gel buffer (2 X): 250 mM Tris-HCl, pH 6.8, 4 mM EDTA, 0.2 % SDS. 
5. 30 % acrylamide-bisacrylamide solution, stored at 4 C. 
6. N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED), stored at 4 C. 
7. Ammonium persulphate: 10 % stock made up in H20 and stored at 4 C (See Note 8).  
8. Tris-Glycine electrophoresis buffer (10 X): 250 mM Tris-HCl, 2.5 M glycine, 1 % 
SDS (See Note 9).  
9. Prestained molecular weight markers. 
10. Bio-Rad Mini-PROTEAN Tetra Cell system. 
11. Bio-Rad PowerPac Universal Power Supply. 
12. Heat block. 
 
2.8 Western Blotting 
1. Nitrocellulose membrane with 0.45 μM pore size. 
2. Whatman 3mm blotting paper 
3. Bio-Rad Trans-Blot Cell. 
4. Bio-Rad PowerPac Universal Power Supply. 
5. Transfer buffer (10 X): 480 mM Tris-Base, 390 mM Glycine, 13 mM SDS (See Note 
10).   
6. PBS-T: PBS containing 0.02 % Tween 20 (See Note 11).  
 
2.9 Detection of S-acylated proteins. 
1. Western blotting membrane incubation box 
2. Orbital rotator 
3. PBS-T: PBS containing 0.02 % Tween 20 (See Note 11).  
4. Blocking Buffer: 5 % non-fat skimmed milk powder in PBS-T (See Note 12).  
5. Appropriate primary antibody (Living Colors® Av Monoclonal anti GFP Antibody 
(JL-8), Clontech). 
6. Secondary antibody diluent: 1 % non-fat skimmed milk powder in PBS-T (See Note 
12).  
7. LI-COR IRDye® 680RD Secondary Antibody raised against the appropriate species 
of primary antibody (See Note 13). For use with the anti-GFP JL8 antibody, we use 
LI-COR IRDye® 680RD Goat anti-Mouse IgG (H + L), catalogue number 925-
680700.  
8. LI-COR Odyssey Imaging System (See Note 14).  
 
3. Methods. 
Unless otherwise stated, all commercially available reagents were used as supplied without 
any further purification. All procedures should be carried out at room temperature unless 
stated otherwise. Prepare all solutions using ultrapure Milli-Q water and store at room 
temperature unless stated otherwise. Culture Human Embryonic Kidney (HEK)-293T cells in 
75 cm2 flasks in DMEM containing L-Glutamine supplemented with 10 % (v/v) FCS at 37 ºC 
in a humidified atmosphere containing 95 % (v/v) air and 5 % (v/v) CO2 according to 
standard procedures [21]. Allow 24 hours between seeding and transfecting the HEK293T 
cells, and 24 hours between transfection and cell harvesting. Harvest and re-seed HEK293T 
cells every 7 days. All HEK293T media should be pre-warmed to 37 ºC before use. 
General details for fatty acid azide synthesis: Dry THF was used directly from a PureSolv 
MD 5 Solvent Purification System by Innovative Technology Inc., and handled under inert 
atmosphere. Flash chromatography was carried out using Merck Kieselgel 60 H silica. 
Analytical thin layer chromatography was carried out using aluminium-backed plates coated 
with Merck Kieselgel 60 GF254 that were visualised using p-anisaldehyde. Nuclear magnetic 
resonance (NMR) spectra were recorded on a 400 MHz Ultrashield Magnet, Prodigy liquid 
nitrogen cryoprobe, AVIII console and a Z420 HP workstation running TopSpin 3.X running 
at 400 MHz (1H NMR) and 101 MHz (13C NMR); an 500 MHz Ascend magnet, BBO multi 
nuc’ Smart probe, AVIIIHD500 console and Z420 HP workstation running TopSpin 3.X 
running at 500 MHz (1H NMR) and 126 MHz (13C NMR) or a 600 MHz Ultrashield 
magnet, BBO multi nuc’ probe, AVII+ console and a  Z420 HP workstation running TopSpin 
3.X running at 600 MHz (1H NMR) or 151 MHz (13C NMR). Chemical shifts are reported 
in parts per million (ppm) in the scale relative to CDCl3, 7.26 ppm for 1H NMR and 77.16 
for 13C NMR; DMSO-d6, 2.50 ppm for 1H NMR and 39.52 for 13C NMR. Coupling 
constants are measured in Hertz (Hz). Low resolution mass spectra (LRMS) were recorded 
on an Agilent 6130 single quadrupole with APCI/ESI dual source, on a ThermoQuest 
Finnigan LCQ DUO electrospray, or on an Agilent 7890A GC system, equipped with a 30 m 
DB5MS column connected to a 5975C inert XL CI MSD with Triple-Axis Detector. MALDI 
were performed on an Axima-CFR from Kratos-Shimadzu. High resolution mass spectra 
(HRMS) were obtained courtesy of the EPSRC National Mass Spectrometry Facility at 
Swansea University, UK. Infrared spectra were recorded on an Agilent 5500a FTIR equipped 
with ATR (Attenuated Total Reflectance) and were reported in cm–1. In vacuo refers to 
evaporation under reduced pressure using a rotary evaporator connected to a diaphragm 
pump, followed by the removal of trace volatiles using a high vacuum (oil) pump. Melting 
points were determined with a Gallenkamp SG92 melting point apparatus and are 
uncorrected. 
 
3.1 Preparation of fatty acid azides. 
Fatty acid azides followed the synthesis outlined in Figure 1.   
1. Preparation of 1,14-tetradecanediol 4 (See Note 15). Add solid LiAlH4 (1.47 g, 38.7 
mmol) to a solution of 1,14-tetradecanedioic acid (5.00 g, 19.35 mmol) in THF (194 
mL) at 0 °C. Allow the reaction to warm to room temperature and stir for 20 h. Upon 
completion, add wet NaSO4 portion-wise until the grey suspension turns white. Stir 
the suspension at room temperature until the white solid is free-flowing, and add solid 
MgSO4 (5 g). Filter the reaction and wash the filter cake with 5 × 50 mL Et2O. 
Evaporate the solvent in vacuo to give the product (3.88 g, 87%) as a white solid. 
δH (600 MHz, DMSO-d6) 4.29 (t, 2H, J 5.0 Hz, 2 × OH), 3.35–3.38 (m, 4H, 2 × 
CH2OH), 1.36–1.42 (m, 4H, 2 × CH2CH2OH), 1.22–1.29 (m, 20H, 10 × CH2). 
δC (151 MHz, DMSO-d6) 60.7, 32.5, 29.1, 29.0, 29.0, 28.9, 25.5. 
LR-MS (MALDI-TOF) 253.2 ([M+Na]+). 
HR-MS calcd for C14H31O2 ([M+H]
+) 231.2318, found 231.2318. 
υmax (thin film, cm-1) 3410, 3351, 2921, 2891, 2850. 
Mp 88–90 °C. 
2. Preparation of 14-bromotetradecan-1-ol 7. Add HBr (48% in H2O, 41 mL) to a 
suspension of diol 4 (3.57 g, 15.5 mmol) in cyclohexane (41 mL). Heat the biphasic 
mixture to reflux for 10 h and then cool to room temperature. Separate the layers and 
extract the aqueous phase with CH2Cl2 (4 × 30 mL). Wash the combined organics 
with NaHCO3 (4 × 20 mL of a saturated aqueous solution), brine (20 mL), dry over 
MgSO4, filter and concentrate in vacuo. Purify the crude residue by column 
chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford 
the product (2.85 g, 63%) as a pale yellow solid (See Note 16). 
δH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.40 (t, 2H, J 6.9 Hz, CH2Br), 
1.80–1.90 (m, 2H, CH2CH2Br), 1.53–1.60 (m, 2H, CH2CH2OH), 1.25–1.46 (m, 20H, 
10 × CH2). 
δC (101 MHz, CDCl3) 63.2, 34.2, 33.0, 33.0, 29.7, 29.7, 29.6, 28.3, 28.9. 
LR-MS (EI+) 294.9 ([M(81Br)]+, 0.5%), 292.9 ([M(79Br)]+, 1%), 276.9 ([M(81Br)-
H2O]
+, 3.5%), 292.9 ([M(79Br)-H2O]
+, 3%), 213.9 ([M-Br]+, 2.5%). 
HR-MS calcd for C14H33ON
79Br+ ([M+NH4]
+) 310.1740, found 310.1744. 
υmax (thin film, cm-1) 3274, 2919, 2850. 
Mp 46–48 °C. 
 
3. Preparation of 14-bromotetradecanoic acid 10. Dissolve CrO3 (3.89 g, 38.92 mmol) in 
concentrated H2SO4 (7.2 mL). Add cold H2O (16.2 mL) slowly and stir the solution 
for 10 min. Add the resulting solution drop-wise to a solution of alcohol 7 (2.85 g, 
9.73 mmol) in acetone (243 mL). Stir the reaction mixture for 20 h before adding H2O 
(100 mL) and CH2Cl2 (40 mL). Separate the layers and extract the aqueous phase with 
CH2Cl2 (4 × 30 mL). Wash the combined organics with brine (30 mL), dry over 
MgSO4, filter and concentrate in vacuo. Purify the crude residue by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the 
product (2.63 g, 88%) as a white solid. 
δH (400 MHz, CDCl3) 3.41 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, 
CH2CO2H), 1.81–1.89 (m, 2H, CH2CH2Br), 1.59–1.68 (m, 2H, CH2CH2CO2H), 1.24–
1.45 (m, 18H, 9 × CH2). 
δC (101 MHz, CDCl3) 179.0, 34.2, 34.0, 33.0, 29.7, 29.7, 29.6, 29.4, 29.2, 28.9, 28.3, 
24.8. 
LR-MS (EI+) 309.0 ([M(81Br)]+, 16%), 307.0 ([M(79Br)]+, 20%), 291.0 ([M(81Br)-
H2O]
+, 13%), 289.0 ([M(79Br)-H2O]
+, 17%), 227.1 ([M-Br]+, 24%). 
HR-MS calcd for C14H26O
79Br ([M-H]‾) 305.1122, found 305.1123. 
υmax (thin film, cm-1) 3036, 2917, 2852, 1696. 
Mp 63–66 °C. 
4. Preparation of 14-azidotetradecanoic acid 13 (See Note 15). Add NaN3 (636 mg, 9.78 
mmol) to a solution of bromide 10 (500 mg, 1.63 mmol) in DMF (6.5 mL). Stir the 
reaction at 80 °C for 40 h and then cool to room temperature. Add a 1:1 mixture  of 
EtOAc/H2O (20 mL), separate the layers and extract the aqueous phase with EtOAc 
(3 × 10 mL). Wash the combined organics with brine (10 mL), dry over MgSO4, filter 
and concentrate in vacuo. Purify the crude residue by column chromatography, 
eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (403 mg, 92%) 
as a white solid (See Note 17). 
δH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.34 (t, 2H, J 7.5 Hz, 
CH2CO2H), 1.55–1.68 (m, 4H, CH2CH2N3, CH2CH2CO2H), 1.23–1.38 (m, 18H, 9 × 
CH2). 
δC (101 MHz, CDCl3) 180.1, 51.6, 34.2, 29.7, 29.6, 29.6, 29.5, 29.4, 29.3, 29.2, 29.0, 
26.9, 24.8. 
LR-MS (ES‾) 268.1 ([M-H]‾, 100%), 240.1 ([M-N2-H]‾, 34%). 
HR-MS calcd for C14H26N3O2 ([M-H]‾) 268.2031, found 268.2028. 
υmax (thin film, cm-1) 3016, 2915, 2848, 2101, 1701. 
Mp 38–40 °C. 
5. Preparation of 1,16-hexadecanediol 5 (See Note 15). Add solid LiAlH4 (1.33 g, 34.9 
mmol) to a solution of 1,16-hexadecanedioic acid (5.00 g, 17.46 mmol) in THF (175 
mL) at 0 °C. Allow the reaction to warm to room temperature and stir for 20 h. Upon 
completion, add wet NaSO4 portion-wise until the grey suspension turns white. Stir 
the suspension until the white solid is free-flowing and add solid MgSO4 (5 g). Filter 
the reaction and wash the filter cake with Et2O (5 × 50 mL). Evaporate the solvent in 
vacuo to afford the product (3.68 g, 82%) as a white solid. 
δH (600 MHz, DMSO-d6) 4.29 (t, 2H, J 4.9 Hz, 2 × OH), 3.34–3.39 (m, 4H, 2 × 
CH2OH), 1.36–1.42 (m, 4H, 2 × CH2CH2OH), 1.22–1.29 (m, 24H, 12 × CH2). 
δC (151 MHz, DMSO-d6) 60.7, 32.5, 29.1, 29.0, 29.0, 29.0, 28.9, 25.5. 
LR-MS (MALDI-TOF) 281.3 ([M+Na]+), 297.3 ([M+K]+). 
HR-MS calcd for C16H35O2 ([M+H]
+) 259.2632, found 259.2632. 
υmax (thin film, cm-1) 3414, 3353, 2919, 2891, 2848. 
Mp 91-94 °C. 
6. Preparation of 16-bromohexadecan-1-ol 8. Add HBr (48% in H2O, 36 mL) to a 
suspension of diol 5 (3.48 g, 13.5 mmol) in cyclohexane (36 mL). Heat the biphasic 
mixture to reflux for 10 h before cooling to room temperature. Separate the layers and 
extract the aqueous phase with CH2Cl2 (4 × 30 mL). Wash the combined organics 
with NaHCO3 (4 × 20 mL of a saturated aqueous solution), brine (20 mL), dry over 
MgSO4, filter and concentrate in vacuo. Purify the crude residue by column 
chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford 
the product (2.40 g, 55%) as a pale yellow solid See Note 16). 
δH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.41 (t, 2H, J 6.9 Hz, CH2Br), 
1.80–1.91 (m, 2H, CH2CH2Br), 1.52–1.62 (m, 2H, CH2CH2OH), 1.25–1.46 (m, 24H, 
12 × CH2). 
δC (101 MHz, CDCl3) 63.3, 34.2, 33.0, 33.0, 29.8, 29.8, 29.7, 29.6, 28.9, 28.3, 25.9. 
LR-MS (EI+) 320.9 ([M(81Br)]+, 0.5%), 318.9 ([M(79Br)]+, 0.5%), 304.9 ([M(81Br)-
H2O]
+, 1%), 302.9 ([M(79Br)-H2O]
+, 1%), 241.8 ([M-Br]+, 1.5%). 
HR-MS calcd for C16H37
79BrON ([M+NH4]
+) 338.2053, found 338.2056. 
υmax (thin film, cm-1) 3274, 2917, 2850. 
Mp 54-56 °C. 
7. Preparation of 16-bromohexadecanoic acid 11. Dissolve CrO3 (3.00 g, 30.0 mmol) in 
concentrated H2SO4 (5.5 mL). Add cold H2O (12.5 mL) slowly and stir the solution at 
room temperature for 10 min. Add the resulting solution drop-wise to a solution of 
alcohol 8 (2.40 g, 7.50 mmol) in acetone (188 mL). Stir the reaction mixture for 20 h 
before adding H2O (100 mL) and CH2Cl2 (40 mL). Separate the layers and extract the 
aqueous phase with CH2Cl2 (4 × 30 mL). Wash the combined organics with brine (30 
mL), dry over MgSO4, filter and concentrate in vacuo. Purify the crude residue by 
column chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford 
the product (2.30 g, 92%) as a white solid. 
δH (400 MHz, CDCl3) 3.41 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, 
CH2CO2H), 1.80–1.90 (m, 2H, CH2CH2Br), 1.59–1.68 (m, 2H, CH2CH2CO2H), 1.25–
1.48 (m, 22H, 11 × CH2). 
δC (101 MHz, CDCl3) 178.6, 34.2, 33.9, 33.0, 29.8, 29.7, 29.6, 29.4, 29.2, 28.9, 28.3, 
24.8. 
LR-MS (EI+) 337.0 ([M(81Br)]+, 5%), 335.0 ([M(79Br)]+, 7%), 317.0 ([M(81Br)-H2O]
+, 
3%), 315.0 ([M(79Br)-H2O]
+, 5%), 257.1 ([M-Br]+, 8.5%), 237.1 ([M-Br-H2O]
+, 
22%). 
HR-MS calcd for C16H30
79BrO ([M-H]‾) 333.1435, found 333.1430. 
υmax (thin film, cm-1) 3034, 2917, 2850, 1696 
Mp 72-74 °C 
8. Preparation of 16-azidohexadecanoic acid 14 (See Note 15). Add NaN3 (582 mg, 8.96 
mmol) to a solution of bromide 11 (500 mg, 1.49 mmol) in DMF (6 mL). Stir the 
reaction at 80 °C for 40 h before cooling to room temperature. Add a 1:1 mixture of 
EtOAc/H2O (20 mL), separate the layers and extract the aqueous phase with EtOAc 
(3 × 10 mL). Wash the combined organics with brine (10 mL), dry over MgSO4, filter 
and concentrate in vacuo. Purify the crude residue by column chromatography, 
eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (402 mg, 91%) 
as a white solid (See Note 17). 
δH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.34 (t, 2H, J 7.5 Hz, 
CH2CO2H), 1.55–1.67 (m, 4H, CH2CH2N3, CH2CH2CO2H), 1.24–1.40 (m, 22H, 11 × 
CH2). 
δC (101 MHz, CDCl3) 180.0, 51.7, 34.2, 29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 29.3, 29.3, 
29.2, 29.2, 29.0, 26.9, 24.8. 
LR-MS (ES-) 268.2 ([M-N2-H]‾, 26%), 296.2 ([M-H]‾, 100%). 
HR-MS calcd for C16H32NO2 ([M-N2+H]
+) 270.2440, found 270.2433. 
υmax (thin film, cm-1) 3014, 2915, 2848, 2103, 1701. 
Mp 48–50 °C. 
9. Preparation of 1,18-octadecanediol 6 (See Note 15). Add solid LiAlH4 (1.44 g, 37.96 
mmol) to a vigorously stirred solution of dimethyl octadecanedioate (5.00 g, 14.9 
mmol). Heat the reaction to reflux and stir at reflux for 20 h. Upon completion, cool 
the reaction to room temperature and add wet NaSO4 portion-wise until the grey 
suspension turns white. Stir the suspension until the white solid is free-flowing, and 
solid MgSO4 (5 g). Filter the reaction and wash the filter cake with Et2O (5 × 50 mL). 
Evaporate the solvent in vacuo to afford the product (4.15 g, 99%) as a white solid. 
δH (600 MHz, DMSO-d6) 4.30 (t, 2H, J 5.1 Hz, 2 × OH), 3.34–3.39 (m, 4H, 2 × 
CH2OH), 1.35–1.43 (m, 4H, 2 × CH2CH2OH), 1.23 (app. br. s., 28H, 14 × CH2). 
δC (151 MHz, DMSO-d6) 60.6, 32.3, 28.8, 28.8, 28.7, 25.3. 
LR-MS (MALDI-TOF) 293.3 ([M+Li]+), 309.3 ([M+Na]+). 
HR-MS calcd for C18H39O2 ([M+H]
+) 287.2945, found 287.2946. 
υmax (thin film, cm-1) 3416, 3353, 2919, 2891. 
Mp 103–106 °C. 
10. Preparation of 18-bromooctadecan-1-ol 9. Add HBr (48% in H2O, 21 mL) to a 
suspension of diol 6 (2.26 g, 7.9 mmol) in cyclohexane (21 mL). Heat the biphasic 
mixture to reflux for 10 h before cooling to room temperature. Separate the layers and 
extract the aqueous phase with CH2Cl2 (4 × 20 mL). Wash the combined organics 
with NaHCO3 (4 × 20 mL of a saturated aqueous solution), brine (20 mL), dry over 
MgSO4, filter and concentrate in vacuo. Purify the crude residue by column 
chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford 
the product (1.65 g, 60%) as a pale yellow solid (See Note 16). 
δH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.40 (t, 2H, J 6.9 Hz, CH2Br), 
1.81–1.89 (m, 2H, CH2CH2Br), 1.53–1.60 (m, 2H, CH2CH2OH), 1.25–1.46 (m, 28H, 
14 × CH2). 
δC (101 MHz, CDCl3) 63.3, 34.2, 33.0, 33.0, 29.8, 29.8, 29.7, 29.6, 28.9, 28.3, 25.9. 
LR-MS (ES+) 332.5 (M(81Br)-H2O, 0.5%), 330.5 (M(
79Br)-H2O, 0.5%). 
HR-MS calcd for C18H41
79BrON ([M+NH4]
+) 366.2366, found 336.2368. 
υmax (thin film, cm-1) 3274, 2917, 2850. 
Mp 59–61 °C. 
11. Preparation of 18-bromooctadecanoic acid 12. Dissolve CrO3 (1.42 g, 14.2 mmol) in 
concentrated H2SO4 (3.5 mL). Add cold H2O (7.9 mL) slowly and stir the solution for 
10 min. Add the resulting solution drop-wise to a solution of alcohol 9 (1.65 g, 4.73 
mmol) in acetone (120 mL). Stir the reaction for 20 h before adding H2O (60 mL) and 
CH2Cl2 (40 mL). Separate the layers and extract the aqueous phase with CH2Cl2 (4 × 
20 mL). Wash the combined organics with brine (20 mL), dry over MgSO4, filter and 
concentrate in vacuo. Purify the crude residue by column chromatography, eluting 
with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (1.43 g, 83%) as a 
white solid (See Note 18). 
δH (400 MHz, CDCl3) 3.41 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, 
CH2CO2H), 1.81–1.90 (m, 2H, CH2CH2Br), 1.59–1.68 (m, 2H, CH2CH2CO2H), 1.25–
1.46 (m, 26H, 13 × CH2). 
δC (101 MHz, CDCl3) 179.6, 34.2, 34.1, 33.0, 29.8, 29.7, 29.7, 29.6, 29.4, 29.2, 28.9, 
28.3, 24.8. 
LR-MS (EI+) 365.0 ([M(81Br)]+, 9%), 363.0 ([M(79Br)]+, 12%), 347.0 ([M(81Br)-
H2O]
+, 5%), 345.0 ([M(79Br)-H2O]
+, 7%), 284.0 ([M-Br]+, 12%), 265.1 ([M-Br-
H2O]
+, 29%). 
HR-MS calcd for C18H34
79BrO2 ([M-H]‾) 361.1748, found 361.1741. 
υmax (thin film, cm-1) 3034, 2915, 2850, 1696. 
Mp 77–80 °C. 
12. Preparation of 18-azidooctadecanoic acid 15 (See Note 15). Add NaN3 (537 mg, 8.3 
mmol) to a solution of bromide 12 (500 mg, 1.38 mmol) in DMF (5.5 mL). Stir the 
reaction at 80 °C for 40 h before cooling to room temperature. Add a 1:1 mixture of 
EtOAc/H2O (30 mL), separate the layers and extract the aqueous phase with EtOAc 
(3 × 10 mL). Wash the combined organics with brine (10 mL), dry over MgSO4, filter 
and concentrate in vacuo. Purify the crude residue by column chromatography, 
eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (403 mg, 90%) 
as a white solid (See Note 16). 
δH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.34 (t, 2H, J 7.5 Hz, 
CH2CO2H), 1.55–1.67 (m, 4H, CH2CH2N3, CH2CH2CO2H), 1.25–1.39 (m, 26H, 13 × 
CH2). 
δC (101 MHz, CDCl3) 180.1, 51.6, 34.2, 29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 29.4, 29.3, 
29.2, 29.0, 26.7, 24.8. 
LR-MS (ES-) 296.3 ([M-N2-H]‾, 24%), 324.1 ([M-H]‾, 100%). 
HR-MS calcd for C18H34N3O2 ([M-H]‾) 324.2657, found 324.2649. 
υmax (thin film, cm-1) 3040, 2915, 2850, 2098, 1696. 
Mp 56–58 °C. 
 
3.2 HEK293T cell culture and seeding. 
1. Warm Trypsin-EDTA and HEK293T Culture Media to 37 ºC in a pre-warmed water 
bath. 
2. In a Laminar flow tissue culture cabinet, remove the media from HEK293T cells 
cultured in a 75 cm2 flask and discard. 
3. Wash cells briefly with 3ml of pre-warmed Trypsin-EDTA and immediately discard. 
4. Add 3ml of pre-warmed Trypsin-EDTA to the cell monolayer and incubate at 37 ºC 
for 5 minutes. 
5. Detach cell monolayer by gently tapping the side of the flask and wash the remaining 
cells off the flask surface by pipetting up and down 5-10 times. Care should be taken 
to ensure all cells are harvested. 
6. Transfer the contents of the flask to a sterile falcon tube and add 7ml of pre-warmed 
HEK293T Culture Media. Pipette up and down five times to mix.  
7. To reseed cells into a new 75 cm2 flask, dilute cells 1:10 by mixing 1 ml of the cells 
with 11ml of HEK293T Culture Media. 
8. Determine cell density using a Neubauer Chamber. Resuspend cells in HEK293T 
Culture Media at a density of approximately 106 cells/ml and seed 500 l/well into 
Poly-D-lysine coated 24-well cell culture plates. 
9. Incubate cells overnight at 37 ºC in a humidified atmosphere containing 95 % air and 
5 % CO2.  
 
3.2 HEK293T cell transfection. 
1. HEK293T should be transfected approximately 24 hours after seeding. 
2. For each well of HEK293T cells to be transfected, set up 2 tubes each containing 50 
uL of Serum Free DMEM. In Tube 1 add up to 3ug plasmid DNA (we used 0.8 ug 
EGFP-SNAP25B + 1.6 ug HA-ZDHHC3). In Tube 2 add two volumes of 
Lipofectamine 2000 reagent per ug of plasmid DNA used (we used 4.8 ul of 
Lipofectamine 2000 reagent). Incubate for 5 minutes at room temperature (See Note 
19).  
3. Mix the contents of the two tubes and incubate the DMEM:DNA:Lipofectamine 2000 
mixture for 20 minutes at room temperature. 
4. Add the transfection complex to one well of the 24-well plate of HEK293T cells.  
5. Incubate cells overnight at 37 ºC in a humidified atmosphere containing 95 % air and 
5 % CO2.  
 
3.3 Metabolic Labelling of Transfected Cells with azido-fatty acid.  
1. Serum-starve transfected HEK293T cells by removing and discarding the culture 
media and replacing it with 500 l/well of DMEM containing L-Glutamine  
supplemented with 1% fatty-acid free BSA (See Note 20). Incubate cells at 37 ºC in a 
humidified atmosphere containing 95 % air and 5 % CO2 for 30 minutes.  
2. Add 500 l/well of DMEM containing L-Glutamine supplemented with 1% fatty-acid 
free BSA and 100µM fatty acid azide  and incubate cells for 4 hours cells at 37 ºC in a 
humidified atmosphere containing 95 % air and 5 % CO2 (See Note 21).  
 3.4 Cell lysis. 
1. Wash cells twice on ice by gently aspirating off the media and replacing it with 1ml 
ice-cold PBS. 
2. Remove the PBS and add 100µl of Lysis Buffer (containing protease inhibitors) to 
each well. Incubate cells on ice for 10 minutes with gentle agitation (See Note 22).  
 
3.5 Click Chemistry and Protein Precipitation 
1. Remove aliquots of 4 mM Alkyne Infrared Dye and 100 mM TBTA from the freezer 
and bring up to room temperature. 
2. Make up 40mM Ascorbic Acid solution by dissolving 0.07g of ascorbic acid in 10 ml 
of H20 and mixing with a magnetic stirrer (See Note 23).  
3. In a 1.5 ml tube, mix 0.12 µl 4 mM Alkyne IR800 dye, 10 µl 40 mM CuSO4, 0.4 µl 
100 mM TBTA and 69.48 µl dH2O (See Note 24).  
4. Add the cell lysate to the click reaction cocktail and vortex to mix. 
5. Add 20 µl of 40mM ascorbic acid to the lysate (See Note 25).  
6. Vortex and incubate for 1 hour at room temperature with end-over-end rotation.    
7. Precipitate proteins using ice-cold acetone. Add 3 volumes (600µl) of ice-cold 
acetone to the tubes and vortex. Incubate at -20 ºC for a minimum of 20 minutes (See 
Note 26).  
8. Centrifuge at 20, 000 x g for 5 minutes at 4 ºC to pellet proteins.  
9. Remove and discard supernatant. Add 1 ml ice-cold 70 % acetone and vortex tube to 
wash pellet.  
10. Centrifuge at 20, 000 x g for 5 minutes at 4 ºC to pellet proteins.  
11. Remove and discard supernatant and allow pellet to air-dry for 5 minutes.  
12. Resuspend pellet in 100 µL of 1 x SDS Lysis Buffer containing 25 mM DTT (See 
Notes 26 and 27).  
 
3.6 SDS-Polyacrylamide Gel electrophoresis and in-gel analysis. 
1. Clean and dry two 1 mm spacer plates and two short plates by washing with 70 % 
ethanol and rinsing in H20. Allow to dry. 
2. Assemble the gel cassette by placing the casting frame upright with the pressure cams 
in the open position and facing forward on a flat surface. With the labeling on the 
spacer plate up, place a short plate on top and slide the two glass plates into the 
casting frame with the short plate facing the front (See Note 28). Secure the glass 
cassette sandwich in the casting frame by engaging the pressure cams. Place the 
casting frame onto the casting gasket, pressure cams facing outwards, and lock onto 
the casting stand by engaging the spring-loaded lever of the casting stand onto the 
spacer plate (See Note 29).  
3. Prepare the resolving gel monomer. For two 12 % gels, mix 5 mL of Resolving gel 
buffer, 4 mL of 30 % acrylamide-bisacrylamide solution and 1 mL H20. Add 200 µL 
of 10 % ammonium persulphate and 8 µL of TEMED and mix. Carefully pipette 4.5 
mL of the resolving gel monomer solution between the glass plates and immediately 
overlay with 500 µL of propan-1-ol. Allow the gel to polymerize for 45 min. Pour off 
the propan-1-ol and rinse the gel surface completely with distilled water. Dry the top 
of the resolving gel with filter paper.  
4. Prepare the stacking gel monomer. Mix 4 mL of Stacking gel buffer, 1.3 mL of 30 % 
acrylamide-bisacrylamide solution and 2.7 mL H20. Add 200 µL of 10 % ammonium 
persulphate and 10 µL of TEMED and mix. Carefully pour on top of the resolving gel 
monomer until the top of the short plate is reached and insert a 15-well comb in the 
gel cassette, aligning the ridge with the top of the short plate. Allow the gel to 
polymerize for 45 min (See Note 30).  
5. Place the gel cassettes into the clamping frame with the short plates pointed inwards 
and clamp into place. Place the clamping frame in the tank and fill the inner and outer 
chamber with 1 L of Tris-Glycine electrophoresis buffer. 
6. Heat the samples in a heat block for 5 minutes at 100 ºC to denature proteins. 
Centrifuge the samples briefly to bring down the condensate.  
7. Load 5-20 μL/well of each sample into the wells with a Hamilton syringe or a pipette 
using gel loading tips along with 5 μL/well of prestained protein standards.  
8. Place the lid on the Mini-PROTEAN Tetra tank ensuring to align the colour-coded 
banana plugs and jacks. Insert the electrical leads into the suitable power supply and 
electrophorese at 180 V constant until the dye front reaches the bottom of the gel.  
9. Turn off the power supply, disconnect the electrical leads and remove the tank lid. 
Pour off and discard the running buffer. 
10. Remove the gel cassettes from the assembly and separate the glass plates to remove 
the gels from the gel cassette. Place the gels in an incubation box containing H20. 
11. To visualize S-acylation of your expression protein via in-gel analysis, place the gel 
on the scanning surface of a LI-COR Odyssey Infrared Imagining system taking care 
not to trap bubbles underneath.  
12. Scan the gel in the 800 nm channel using the Image Studio Software Acquire ribbon 
(See Note 31).  
 
3.7 Electrophoretic transfer of proteins to nitrocellulose membranes 
1. For each gel to be transferred, cut one nitrocellulose membrane and two Whatman 
filter paper to the dimensions of the gel (See Notes 32 and 33).  
2. Soak the gel, cut nitrocellulose membranes and filter paper in transfer buffer.  
3. Prepare the gel sandwich: Open the gel holder cassette from the Bio-Rad Trans-Blot 
Electrophoretic Transfer Cell with the grey side down. Place a pre-wetted fiber pad on 
the grey side of the cassette. Place the wet filter paper on the fiber pad and place the 
gel on top. Place the nitrocellulose membrane on top of the gel and the final piece of 
filter paper on top of the membrane (See Note 34).  
4.  Add a fiber pad on top and close and lock the gel holder cassette with the white latch.  
5. Place the gel holder cassette in the tank, ensuring the grey side is towards the plate 
cathode, and completely fill the tank with transfer buffer. 
6. Place the lid on the Transfer Cell and insert the electrical leads into the suitable power 
supply and run at 120 mA overnight. 
7. Upon completion, disassemble the blotting sandwich and place the membrane in an 
incubation box containing PBS-T (See Note 35).  
 
3.8 Western blotting  
1. Wash membranes once in PBS-T.  
2. Place the membranes in an incubation box and block the membranes in Blocking 
buffer for 45 minutes with gentle agitation. 
3. Prepare the primary antibody by diluting in PBST using the manufacturer’s 
recommended dilution for Western blot applications (See Note 36). Use enough 
antibody solution to completely cover the membrane. Incubate the membrane in 
diluted primary antibody for between 1 hour at room temperature to overnight at 4ºC, 
with gentle agitation (See Note 37).  
4. Wash the membranes by pouring off the primary antibody solution and rinsing the 
membranes 5 X in PBS-T for 5 minutes each, with vigorous agitation (See Note 38).  
5. Prepare the secondary antibody by diluting the IRDye secondary antibody 1:10,000 in 
secondary antibody diluent. Use enough antibody solution to completely cover the 
membrane. Incubate the membrane in diluted secondary antibody for 45 minutes at 
room temperature with gentle agitation. 
6. Wash the membranes by pouring off and discarding the secondary antibody solution. 
Rinse the membranes 5 X in PBS-T for 5 minutes each, with vigorous agitation. 
7. Rinse membranes in PBS to remove residual Tween 20 (See Note 39).  
8. Image the blots using a LI-COR Odyssey Infrared Imagining system by placing the 
membranes on the scanning surface and taking care to ensure no bubbles are trapped 
underneath. Scan the membranes simultaneously in the 700 nm and 800 nm channels 
using the Image Studio Software Acquire ribbon.  
 
4. Notes 
1. Longer chain saturated fatty acid azide stocks (C18:0 and longer) may need warming 
until the solution becomes clear before use. 
2. Add 100 mL of 10 X PBS to 900 mL of water for use. 
3. IRDyes should be protected from light and repeated freeze-thaw cycles should be 
avoided. 
4. Prepare immediately before use. 
5. Acetone is flammable and should be stored in a spark-free freezer.  
6. SDS precipitates at low temperatures; if this occurs, warm buffer in a water bath 
before use.  
7. Add 250 µL of 4 X SDS Lysis buffer to 725 µL of water and add 25 µL of 1 M DTT.  
8. The ammonium persulphate solution can be stored at 4 °C for 7 days. 
9. Add 100 mL of 10 X Tris-Glycine electrophoresis buffer to 900 mL of water. 
10. Add 250 mL of 10 X Transfer buffer to 1750 mL of water and add 500 mL of 
methanol. 
11. Add 2 mL of 10 % Tween 20 to 1 L of PBS. 
12. This should be made up fresh each time. 
13. Store the IRDye secondary antibody in darkness and minimize exposure to light. 
14. For dual imaging the system requires two infrared channels with 685 and 785 nm 
lasers. 
15. Perform reaction under a N2 atmosphere. 
16. For the mono-bromination, reaction time and vigorous stirring were crucial for 
success to prevent bis-bromination.  
17. For azide addition the reaction should be monitored carefully by TLC to ensure the 
reaction has reached completion. Addition of additional azide was found to be 
problematic with this process.  
18. For the reduction of the bis-carboxylic acids the reaction generally proceeded 
efficiently at room temperature, however, this was not reliable with 1,18-
octadecanedioic acid, therefore for reproducibility we used 1,18-dimethyl 
octadecanedioate as the substrate, performing the reduction at reflux in THF.  
19. It is possible to scale up the transfection by multiplying by the number of wells to be 
transfected. 
20. For incubation times of up to 8 hours, it is not necessary to use aseptic techniques. 
21. Depending on the expression level and extent of S-acylation of the protein of interest, 
it may be necessary to increase the incubation time beyond 4 hours. In this case, 
aseptic techniques should be used especially in the case of overnight incubations. 
Prepare the DMEM containing L-Glutamine supplemented with 1% fatty-acid free 
BSA and 100µM fatty acid azide and in a laminar flow hood use a syringe to pass the 
media through a 0.22 µm sterile filter.  
22. Cell lysates may be frozen by directly transferring the plates to -20 ºC allowing the 
procedure to be continued at a later date.  
23. This should be made up fresh each time. The ascorbic acid may take several minutes 
to dissolve. 
24. The total volume per lysate should equal 80µl. If performing multiple click reactions, 
scale the reaction volume up accordingly and aliquot 80 µl of the click reaction mix 
per experimental replicate into separate 1.5 ml tubes. 
25. Final concentrations are 2.5 µM Azide Dye, 2mM CuSO4, 0.2mM TBTA and 4mM 
Ascorbic Acid. Total volume including lysate is 200µl. 
26. Samples may be stored at -20 ºC allowing the procedure to be continued at a later 
date. 
27. Vigorous vortexing may be required to ensure pellet is fully resuspended in the SDS 
Lysis Buffer. 
28. Ensure that the plates are flush on a level surface to minimize the risk of leaking. 
29. Ensure the grey casting stand gaskets are clean and dry before use. 
30. Gels in a cassette sandwich may be made ahead and stored at 4 °C for a few days. 
Ensure that the gels remain hydrated by wrapping the glass plates first in tissue paper 
soaked in water and then in cling film. 
31. If the signal is too strong, the saturated pixels will appear as cyan in the image. In this 
case, re-scan using a lower intensity setting. 
32. We cut membranes to 6 x 9cm.  
33. Always wear gloves when handling membranes to prevent contamination. 
34. Remove any air bubbles which may have formed by using a glass tube to roll out any 
air bubbles. 
35. The membranes can be stored in PBS-T for up to 48 hours in the dark at 4 °C.   
36. For the anti-GFP JL8 antibody, we dilute 1:3000. 
37. Optimal incubation times will vary depending on the primary antibody. 
38. The diluted primary antibody solution may be stored at – 20 ºC and reused.  
39. If the blot is prepared in advance, air-dry the blot and store in the dark until ready to 
image. 
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